Enhanced Cloud Offering Builds on Success of Oracle Argus Safety 7.0, Now Includes Oracle Argus Japan, Oracle Argus Analytics and Oracle Argus Insight
Out-of-the-Box Integration Automates Adverse Event Data Transfer Using E2B Standards to Increase Efficiency and Improve Safety Data Quality
LOS ANGELES, CA — (Marketwired) — 04/15/13 — (OTCQB: MMRF) ("MMR") today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the Company-s anti-CD20 monoclonal antibody assets, U.S. Serial No. 11/855,943, under the title, "Antibodies and Methods for Making and Using Them." This is the first U.S. patent to be granted for the Company-s anti-CD20 monoclonal antibodies, which have particular utility in fighting cancers. The anti-
Cloud-Based Clinical Trial Operations Software Delivers Enhanced Planning, Sourcing, and Tracking Capabilities to Support Phase I Trials and Complex Multi-Arm Studies
Latest Win Strengthens Oracle Health Sciences- Momentum Across Asia
LOS ANGELES, CA — (Marketwire) — 11/19/12 — (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3. The Company has held talks with several privately held biotech companies who are finding it difficult to get
MALVERN, PA — (Marketwire) — 03/08/12 — Y-Prime Technologies LLC, a premier eClinical products and consulting company, is introducing two new software solutions, Prime eMVR and Prime IxR , that will optimize management and enhance performance of global clinical trials."For years, our consulting business has thrived providing high level integration and customization expertise leveraging our experience in both biopharmaceutical research and information technology," explains Y-Prime